Total Payments
$3,018
2021 Payments
$23.89
Companies
30
Transactions
209
Medicare Patients
1,845
Medicare Billing
$187,278
Payment Breakdown by Category
Food & Beverage$2,837 (94.0%)
Education$180.61 (6.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,837 | 193 | 94.0% |
| Education | $180.61 | 16 | 6.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $464.43 | 36 | $0 (2020) |
| Amgen Inc. | $428.96 | 27 | $0 (2020) |
| Genentech USA, Inc. | $279.20 | 19 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $241.09 | 17 | $0 (2020) |
| PFIZER INC. | $220.10 | 16 | $0 (2020) |
| Janssen Biotech, Inc. | $182.85 | 12 | $0 (2020) |
| Exelixis Inc. | $163.97 | 16 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $130.76 | 8 | $0 (2020) |
| Incyte Corporation | $110.85 | 7 | $0 (2020) |
| Daiichi Sankyo Inc. | $89.16 | 6 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $23.89 | 2 | Acrotech Biopharma LLC ($11.97) |
| 2020 | $396.36 | 25 | Amgen Inc. ($51.47) |
| 2019 | $1,258 | 80 | Novartis Pharmaceuticals Corporation ($184.48) |
| 2018 | $450.48 | 31 | Amgen Inc. ($103.95) |
| 2017 | $888.79 | 71 | Exelixis Inc. ($163.97) |
All Payment Transactions
209 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/28/2021 | Acrotech Biopharma LLC | BELEODAQ (Drug) | Education | In-kind items and services | $11.97 | General |
| Category: ONCOLOGY | ||||||
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 08/25/2020 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Oncology | ||||||
| 03/09/2020 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: ONCOLOGY | ||||||
| 03/05/2020 | Janssen Biotech, Inc. | DARZALEX (Biological), IMBRUVICA | Food and Beverage | In-kind items and services | $12.35 | General |
| Category: Oncology | ||||||
| 02/28/2020 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Oncology | ||||||
| 02/27/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | GILOTRIF (Drug) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: ONCOLOGY | ||||||
| 02/24/2020 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Oncology | ||||||
| 02/20/2020 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $17.73 | General |
| Category: Oncology | ||||||
| 02/19/2020 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $19.14 | General |
| Category: Hematology/Oncology | ||||||
| 02/17/2020 | Bayer HealthCare Pharmaceuticals Inc. | Stivarga (Drug) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: Oncology | ||||||
| 02/12/2020 | Amgen Inc. | Vectibix (Biological) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Oncology | ||||||
| 02/11/2020 | Amgen Inc. | Kyprolis (Drug), XGEVA | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: Oncology | ||||||
| 02/10/2020 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological), LENVIMA | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: ONCOLOGY | ||||||
| 02/06/2020 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: ONCOLOGY | ||||||
| 02/05/2020 | Novartis Pharmaceuticals Corporation | PIQRAY (Drug) | Food and Beverage | In-kind items and services | $11.05 | General |
| Category: ONCOLOGY | ||||||
| 02/04/2020 | Celgene Corporation | Revlimid (Drug), Pomalyst | Food and Beverage | Cash or cash equivalent | $15.64 | General |
| Category: Hematology | ||||||
| 02/03/2020 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $11.89 | General |
| Category: ONCOLOGY | ||||||
| 01/31/2020 | Amgen Inc. | Prolia (Biological), XGEVA | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: Bone Health | ||||||
| 01/29/2020 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: ONCOLOGY | ||||||
| 01/24/2020 | PFIZER INC. | INLYTA (Drug), BAVENCIO, LORBRENA | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: ONCOLOGY | ||||||
| 01/22/2020 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Oncology | ||||||
| 01/15/2020 | PFIZER INC. | IBRANCE (Drug) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: ONCOLOGY | ||||||
| 01/10/2020 | Genentech USA, Inc. | VENCLEXTA (Biological) | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: BioOncology | ||||||
| 01/09/2020 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 359 | 476 | $179,474 | $42,930 |
| 2022 | 9 | 387 | 535 | $112,122 | $41,731 |
| 2021 | 8 | 464 | 780 | $110,744 | $55,501 |
| 2020 | 12 | 635 | 968 | $99,062 | $47,117 |
Total Patients
1,845
Total Services
2,759
Medicare Billing
$187,278
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 182 | 277 | $88,640 | $20,564 | 23.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 72 | 72 | $40,248 | $10,239 | 25.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 53 | 75 | $34,050 | $8,236 | 24.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 24 | 24 | $10,152 | $2,536 | 25.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 28 | 28 | $6,384 | $1,355 | 21.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 158 | 249 | $47,994 | $17,715 | 36.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 45 | 62 | $17,960 | $6,695 | 37.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 46 | 81 | $11,889 | $4,447 | 37.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 23 | 25 | $9,213 | $3,835 | 41.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 53 | 56 | $7,371 | $2,488 | 33.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 22 | 22 | $5,966 | $2,229 | 37.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 13 | 13 | $4,657 | $1,854 | 39.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 14 | 14 | $4,082 | $1,458 | 35.7% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 13 | 13 | $2,990 | $1,009 | 33.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 173 | 380 | $49,400 | $26,480 | 53.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 54 | 61 | $20,252 | $9,481 | 46.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 65 | 143 | $17,732 | $7,870 | 44.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 53 | 53 | $10,441 | $5,127 | 49.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 69 | 80 | $5,809 | $3,310 | 57.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 20 | 21 | $4,704 | $2,009 | 42.7% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 14 | 24 | $1,632 | $715.92 | 43.9% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Facility | 2021 | 16 | 18 | $774.00 | $506.88 | 65.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 193 | 350 | $25,200 | $13,007 | 51.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 63 | 155 | $19,220 | $8,827 | 45.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 47 | 54 | $17,928 | $8,629 | 48.1% |
About Dr. Dayra Avila Lima, M.D
Dr. Dayra Avila Lima, M.D is a Internal Medicine healthcare provider based in Jacksonville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/14/2010. The National Provider Identifier (NPI) number assigned to this provider is 1679881502.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dayra Avila Lima, M.D has received a total of $3,018 in payments from pharmaceutical and medical device companies, with $23.89 received in 2021. These payments were reported across 209 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($2,837).
As a Medicare-enrolled provider, Avila Lima has provided services to 1,845 Medicare beneficiaries, totaling 2,759 services with total Medicare billing of $187,278. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Hematology & Oncology, Hematology & Oncology
- Location Jacksonville, FL
- Active Since 09/14/2010
- Last Updated 04/28/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1679881502
Products in Payments
- KEYTRUDA (Biological) $241.09
- Neulasta (Biological) $209.22
- Cabometyx (Drug) $163.97
- KISQALI (Drug) $139.14
- PROMACTA (Drug) $113.99
- JAKAFI (Drug) $110.85
- DARZALEX (Biological) $102.20
- IBRANCE (Drug) $101.34
- CALQUENCE (Drug) $96.54
- IMBRUVICA (Drug) $80.65
- GILOTRIF (Drug) $80.51
- VENCLEXTA (Biological) $76.28
- INJECTAFER (Drug) $71.68
- XARELTO (Drug) $69.16
- Imbruvica (Drug) $65.26
- Venclexta (Drug) $64.05
- MEKINIST (Drug) $63.22
- TECENTRIQ (Biological) $59.72
- JADENU (Drug) $59.58
- Nplate (Biological) $58.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Jacksonville
Siddharth Wayangankar, Md, MD
Internal Medicine — Payments: $1.3M
Internal Medicine $1.3M
Dr. Alan Miller, M.d, M.D
Internal Medicine — Payments: $770,575
Internal Medicine $770,575
Kalina Sanders, M.d, M.D
Internal Medicine — Payments: $626,907
Internal Medicine $626,907
Jose Soto Soto, Md, MD
Internal Medicine — Payments: $576,809
Internal Medicine $576,809
Dr. Jennifer Fulton, Md, MD
Internal Medicine — Payments: $556,016
Internal Medicine $556,016
Dr. Francis Farraye, M.d, M.D
Internal Medicine — Payments: $504,399
Internal Medicine $504,399